Biondo Investment Advisors’s Transmedics TMDX Stock Holding History

Biondo Investment Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.93M	Sell	44,155 -13,815	-24%	-$1.17M	0.36%	49
2026 Q1	$5.76M	Buy	57,970 +755	+1%	+$98.5K	0.74%	38
2025 Q4	$6.96M	Sell	57,215 -1,160	-2%	-$146K	0.84%	36
2025 Q3	$6.55M	Sell	58,375 -105	-0.2%	-$12.3K	0.82%	37
2025 Q2	$7.84M	Buy	58,480 +410	+0.7%	+$45K	1.03%	34
2025 Q1	$3.91M	Buy	58,070 +4,620	+9%	+$318K	0.55%	42
2024 Q4	$3.33M	Sell	53,450 -1,625	-3%	-$151K	0.46%	42
2024 Q3	$8.65M	Buy	55,075 +1,670	+3%	+$257K	1.19%	35
2024 Q2	$8.04M	Buy	+53,405	New	+$6.41M	1.19%	34

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Biondo Investment Advisors's TMDX Position: Q2 2026 in Review

Biondo Investment Advisors reduced its Transmedics (TMDX) stake by 24% in Q2 2026, selling an estimated $1.17M and leaving 44,155 shares worth $2.93M. The position accounts for 0.36% of the portfolio, ranked #49.

Biondo Investment Advisors first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.65M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Biondo Investment Advisors held 44,155 shares of Transmedics worth $2.93M as of Q2 2026.
Biondo Investment Advisors sold 13,815 Transmedics shares in Q2 2026, an estimated $1.17M.
Transmedics made up 0.36% of Biondo Investment Advisors's portfolio in Q2 2026, its #49 holding.
Biondo Investment Advisors first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
Biondo Investment Advisors's Transmedics position peaked at $8.65M in Q3 2024.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Biondo Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.